A detailed history of Mariner, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Mariner, LLC holds 30,486 shares of NEO stock, worth $499,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,486
Previous 30,560 0.24%
Holding current value
$499,665
Previous $423,000 6.15%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$13.4 - $17.73 $991 - $1,312
-74 Reduced 0.24%
30,486 $449,000
Q2 2024

Aug 13, 2024

SELL
$13.01 - $15.77 $36,974 - $44,818
-2,842 Reduced 8.51%
30,560 $423,000
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $51,951 - $62,039
-3,695 Reduced 9.96%
33,402 $525,000
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $11,296 - $20,066
968 Added 2.68%
37,097 $600,000
Q3 2023

Nov 13, 2023

SELL
$12.15 - $17.85 $78,695 - $115,614
-6,477 Reduced 15.2%
36,129 $444,000
Q2 2023

Aug 11, 2023

SELL
$14.1 - $19.83 $50,351 - $70,812
-3,571 Reduced 7.73%
42,606 $684,000
Q1 2023

May 12, 2023

SELL
$9.09 - $19.45 $82,364 - $176,236
-9,061 Reduced 16.4%
46,177 $804,000
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $180 - $337
28 Added 0.05%
55,238 $510,000
Q3 2022

Nov 10, 2022

BUY
$7.86 - $12.91 $29,993 - $49,264
3,816 Added 7.42%
55,210 $475,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $8,154 - $16,135
1,155 Added 2.3%
51,394 $418,000
Q1 2022

May 13, 2022

BUY
$12.15 - $35.28 $37,458 - $108,768
3,083 Added 6.54%
50,239 $610,000
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $152,724 - $242,886
-5,009 Reduced 9.6%
47,156 $1.61 Million
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $14,622 - $18,434
351 Added 0.68%
52,165 $2.52 Million
Q2 2021

Aug 24, 2021

SELL
$36.62 - $51.69 $50,462 - $71,228
-1,378 Reduced 2.59%
51,814 $2.34 Million
Q1 2021

May 07, 2021

BUY
$41.56 - $59.88 $2.21 Million - $3.19 Million
53,192 New
53,192 $2.57 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.